Search Results - "Murray, Tracey K"

Refine Results
  1. 1

    Impaired glymphatic function and clearance of tau in an Alzheimer's disease model by Harrison, Ian F, Ismail, Ozama, Machhada, Asif, Colgan, Niall, Ohene, Yolanda, Nahavandi, Payam, Ahmed, Zeshan, Fisher, Alice, Meftah, Soraya, Murray, Tracey K, Ottersen, Ole P, Nagelhus, Erlend A, O'Neill, Michael J, Wells, Jack A, Lythgoe, Mark F

    Published in Brain (London, England : 1878) (01-08-2020)
    “…The glymphatic system, that is aquaporin 4 (AQP4) facilitated exchange of CSF with interstitial fluid (ISF), may provide a clearance pathway for protein…”
    Get full text
    Journal Article
  2. 2

    Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates by Falcon, Benjamin, Cavallini, Annalisa, Angers, Rachel, Glover, Sarah, Murray, Tracey K., Barnham, Luanda, Jackson, Samuel, O'Neill, Michael J., Isaacs, Adrian M., Hutton, Michael L., Szekeres, Philip G., Goedert, Michel, Bose, Suchira

    Published in The Journal of biological chemistry (09-01-2015)
    “…Intracellular Tau inclusions are a pathological hallmark of several neurodegenerative diseases, collectively known as the tauopathies. They include Alzheimer…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Transcriptional Signatures of Tau and Amyloid Neuropathology by Castanho, Isabel, Murray, Tracey K., Hannon, Eilis, Jeffries, Aaron, Walker, Emma, Laing, Emma, Baulf, Hedley, Harvey, Joshua, Bradshaw, Lauren, Randall, Andrew, Moore, Karen, O’Neill, Paul, Lunnon, Katie, Collier, David A., Ahmed, Zeshan, O’Neill, Michael J., Mill, Jonathan

    Published in Cell reports (Cambridge) (11-02-2020)
    “…Alzheimer’s disease (AD) is associated with the intracellular aggregation of hyperphosphorylated tau and the accumulation of β-amyloid in the neocortex. We use…”
    Get full text
    Journal Article
  5. 5

    CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's disease by Weir, Heather J M, Murray, Tracey K, Kehoe, Patrick G, Love, Seth, Verdin, Eric M, O'Neill, Michael J, Lane, Jon D, Balthasar, Nina

    Published in PloS one (06-11-2012)
    “…Progressive mitochondrial dysfunction contributes to neuronal degeneration in age-mediated disease. An essential regulator of mitochondrial function is the…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    In Vivo Imaging of Tau Pathology Using Magnetic Resonance Imaging Textural Analysis by Colgan, Niall, Ganeshan, Balaji, Harrison, Ian F, Ismail, Ozama, Holmes, Holly E, Wells, Jack A, Powell, Nick M, O'Callaghan, James M, O'Neill, Michael J, Murray, Tracey K, Ahmed, Zeshan, Collins, Emily C, Johnson, Ross A, Groves, Ashley, Lythgoe, Mark F

    Published in Frontiers in neuroscience (06-11-2017)
    “…Non-invasive characterization of the pathological features of Alzheimer's disease (AD) could enhance patient management and the development of therapeutic…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression by Chai, Xiyun, Wu, Su, Murray, Tracey K, Kinley, Robert, Cella, Claire V, Sims, Helen, Buckner, Nicola, Hanmer, Jenna, Davies, Peter, O'Neill, Michael J, Hutton, Michael L, Citron, Martin

    Published in The Journal of biological chemistry (30-09-2011)
    “…The microtubule-associated protein Tau plays a critical role in the pathogenesis of Alzheimer disease and several related disorders (tauopathies). In the…”
    Get full text
    Journal Article
  14. 14

    Loss of MicroRNA-7 Regulation Leads to α-Synuclein Accumulation and Dopaminergic Neuronal Loss In Vivo by McMillan, Kirsty J., Murray, Tracey K., Bengoa-Vergniory, Nora, Cordero-Llana, Oscar, Cooper, Jane, Buckley, Amy, Wade-Martins, Richard, Uney, James B., O’Neill, Michael J., Wong, Liang F., Caldwell, Maeve A.

    Published in Molecular therapy (04-10-2017)
    “…Abnormal alpha-synuclein (α-synuclein) expression and aggregation is a key characteristic of Parkinson’s disease (PD). However, the exact mechanism(s) linking…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease by Murray, Tracey K, Messenger, Marcus J, Ward, Mark A, Woodhouse, Sandra, Osborne, David J, Duty, Susan, O'Neill, Michael J

    Published in Pharmacology, biochemistry and behavior (01-09-2002)
    “…The aim of the present studies was to examine the ability of a potent, systemically active, selective Group II mGlu receptor (mGluR2/3) agonist, 1 R,4 R,5 S,6…”
    Get full text
    Journal Article
  17. 17

    Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease by O'Neill, Michael J, Murray, Tracey K, Whalley, Katherine, Ward, Mark A, Hicks, Caroline A, Woodhouse, Sandra, Osborne, David J, Skolnick, Phil

    Published in European journal of pharmacology (20-02-2004)
    “…Recent developments in the molecular biology and pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors has led to the…”
    Get full text
    Journal Article
  18. 18

    Electrical and Network Neuronal Properties Are Preferentially Disrupted in Dorsal, But Not Ventral, Medial Entorhinal Cortex in a Mouse Model of Tauopathy by Booth, Clair A, Ridler, Thomas, Murray, Tracey K, Ward, Mark A, de Groot, Emily, Goodfellow, Marc, Phillips, Keith G, Randall, Andrew D, Brown, Jonathan T

    Published in The Journal of neuroscience (13-01-2016)
    “…The entorhinal cortex (EC) is one of the first areas to be disrupted in neurodegenerative diseases such as Alzheimer's disease and frontotemporal dementia. The…”
    Get full text
    Journal Article
  19. 19

    Imbalance in the response of pre- and post-synaptic components to amyloidopathy by Stephen, Terri-Leigh, Tamagnini, Francesco, Piegsa, Judith, Sung, Katherine, Harvey, Joshua, Oliver-Evans, Alice, Murray, Tracey K., Ahmed, Zeshan, Hutton, Michael L., Randall, Andrew, O’Neill, Michael J., Jackson, Johanna S.

    Published in Scientific reports (16-10-2019)
    “…Alzheimer’s disease (AD)-associated synaptic dysfunction drives the progression of pathology from its earliest stages. Amyloid β (Aβ) species, both soluble and…”
    Get full text
    Journal Article
  20. 20

    Synaptic alterations associated with disrupted sensory encoding in a mouse model of tauopathy by Meftah, Soraya, Cavallini, Annalisa, Murray, Tracey K, Jankowski, Lukasz, Bose, Suchira, Ashby, Michael C, Brown, Jonathan T, Witton, Jonathan

    Published in Brain communications (2024)
    “…Synapse loss is currently the best biological correlate of cognitive decline in Alzheimer's disease and other tauopathies. Synapses seem to be highly…”
    Get full text
    Journal Article